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To determine whether complex cardiovascular in- 
terventtonal procedures (imluding coronary stent 
implantation, directional atherectomy, aortk val- 
vuloplasty, and the use of an intraaortic balloon 
pump or cardiopulmonary bypass support) are as- 
sociated with an increased liketiheed of vascular 
access site comptkations, 2,400 consecutive car- 
diac catheterization procedures were prospective- 
ly screened over a 1Zmonth study period. Compli- 
cations occurred in 35 patients after 39 proce- 
dures (1.6%) and inebuled the need for vascular 
surgkal repair (17 patients), blood transfuston 
(26 patients) and systemk antibiitk therapy (7 
patients). The incidence of complications after 
1,519 diagnostic studies was 0.6%, after 698 
conventional coronary balloon angkpfasties 2.6%, 
and after 183 cemplex interventions 6.0% (p 
<0.0001); 43% of the complkatiins occurred af- 
ter precedures of >2 hours’ duration and 14% ec- 
curred in patients in whem arterial sheaths re- 
mained in situ for >24 hours. Detailed demo 
graphic and procedural characteristics were 
compared between the 35 patients wfth vascular 
compgcations and 150 patients randomly drawn 
from a computerized database of the uncomplicat- 
ed procedures performed during the screening pe- 
riod. By univarfate analysis with correctton for 
mufttpte comparisons, variables predicting the 
likelihood of vascular comptkations included: pert- 
procedural use ef hepatin (p <O.OOl) or fibrbtolyt- 
ic therapy (p <O.OOl), arterial sheath size LSFr (p 
<O.OOl), patient age ~65 years (p = O.Ol), and 
the presence of peripheral vascular disease 
(p = 0.03). 
The results of this study suggest that the over- 
all imidence of access site complications is low 
but increases with the use of complex cardiovas- 
cular interventional procedures. Further refine- 
ments in the caliber of the new devices, vigilant 
monitoring of adjunctive anticoagulant therapy, 
and careful patient selection may reduce the mor- 
bidii and increase the safety of these procedures. 
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S ince the advent of diagnostic cardiac catheteriza- tion >25 years ago, the complexity of diagnostic and therapeutic coronary angiographic proce- 
dures has increased considerably. This has resulted, in 
part, from an expansion of the indications for percuta- 
neous coronary intervention to include older and more 
hemodynamically unstable patients, and patients with 
more extensive coronary and peripheral vascular dis- 
ea~e.l-~ In addition, the introduction of a variety of new 
devices for the treatment of coronary arterial disease, 
including atherectomy catheters, metallic stems and cir- 
culatory support devices, has necessitated the use of 
both large caliber guiding catheters and arterial 
sheaths, and intensive periprocedural anticoagulant and 
librinolytic therapy.5-7 The hazards associated with the 
use of these new devices include a potentially greater 
risk of arterial injury at the access site. Previous studies 
have reported the incidence of arterial complications af- 
ter diagnostic cardiac catheterizatiorF2**-ii and percu- 
taneous transluminal coronary angioplasty 
(PTCA),3J2-*5 but the incidence of peripheral vascular 
complications after more complex interventional prcce- 
dures has not been systematically evaluated. The aims 
of this study, therefore, were (1) to characterize and to 
compare the risks of peripheral vascular injury after di- 
agnostic cardiac catheterization, conventional PTCA, 
and complex coronary interventional procedures; and 
(2) to identify clinical and procedural factors that pre 
diet the likelihood of these complications. 
MElllOD6 
Patknt sekctkn and dtnkal am All 
patients undergoing diagnostic or therapeutic cardiac 
catheterization at the University of Michigan Medical 
Center were prospectively evaluated over a 1Zmonth 
study period. Each patient was interviewed and exam- 
ined by a physician or physician’s assistant immediately 
before the procedure. The clinical variables recorded in- 
cluded patient age, sex, height and weight, presenting 
symptoms, risk factors for arteriosclerotic disease, and 
the presence or absence of clinically detectable periph- 
eral vascular disease. The procedural parameters re- 
corded included the type of catheterization procedure 
performed, the size of the arterial and venous sheaths, 
the peri- or postprocedural use of antiplatelet, antico- 
agulant or fibrinolytic therapy, the duration of the pro- 
cedure, the length of time from procedure completion 
until sheath removal, and the duration of bedrest after 
sheath removal. Patients undergoing outpatient diagnos- 
tic procedures were examined for evidence of access site 
complications immediately before discharge and were 
then interviewed by telephone 48 to 72 hours later. Pa- 
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tients remaining in the hospital were examined daily for 
the duration of the hospital stay. When vascular injury 
was suspected, duplex color flow Doppler imaging was 
performed as previously described,i6 and a vascular sur- 
gical opinion was obtained. All complications were pro- 
spectively recorded, and the subsequent course of each 
patient in this group was then followed to document the 
need for and timing of surgical repair, and the nature of 
the arterial injury as identified at the time of surgery. 
Details of the vascular surgical management of the pe- 
ripheral vascular complications of cardiac catheteriza- 
tion procedures at our institution have been previously 
published.i7 
Pros&Ural MIS: Ninety-nine percent of the cardi- 
ac catheterization procedures during the study period 
were performed from a percutaneous femoral arterial or 
venous approach, the remainder were performed from 
the brachial approach. Arterial punctures for diagnostic 
procedures were performed predominantly by junior 
cardiology fellows; those for interventional procedures 
were performed by senior cardiology fellows or by 1 of 6 
attending physicians. Diagnostic procedures were per- 
formed through 6, 7 or 8Fr arterial sheaths. Heparin 
was not administered routinely during elective proce- 
dures; in stable patients, intravenous heparin infusions 
were discontinued >4 hours before arterial needle puno 
ture. In patients undergoing emergency cardiac cathe- 
terization soon after the administration of thrombolytic 
therapy and heparin for acute myocardial infarction, 
the sheaths remained in situ after the completion of the 
procedure until the fibrinogen level had risen to 2150 
mg/dl and the activated partial thromboplastin time 
had returned to the normal range. All patients undergo- 
ing elective PTCA were pretreated with oral aspirin 
(325 mg/day) and received intraprocedural heparin 
(10,000 to 15,000 U intravenous bolus, then 5,000 U 
intravenously each hour). Therapy with heparin was 
not continued after uncomplicated procedures, and the 
sheaths (7 or 8Fr) were removed approximately 4 hours 
after the last heparin bolus. Patients with suboptimal 
angiographic results were treated overnight with an in- 
fusion of intravenous heparin (approximately 1,000 U/ 
hour) and had their sheaths removed the following 
morning, 4 hours after discontinuation of heparin. Pro- 
cedural details of the complex procedures have been 
previously described5-7 In brief, coronary stems were 
placed through 8, 9 or IOFr guiding catheters and ar- 
terial sheaths, coronary atherectomy was performed 
through 11 Fr guiding catheters, intraaortic balloon 
pumps were placed through 9.5 or 10.5Fr sheaths, aor- 
tic balloon valvuloplasty procedures were performed 
through 12 or 14Fr sheaths, and percutaneous cardio- 
pulmonary support was instituted through 18 or 21 Fr 
arterial and venous sheaths. The anticoagulation regi- 
men for most complex interventions was similar to that 
described for conventional PTCA. Patients in whom 
coronary stems were implanted were pretreated with 
oral persantine and intravenous dextran (in addition to 
oral aspirin), and continued with infusion of heparin 
at therapeutic concentrations until oral anticoagulation 
with coumadin was established. Before sheath removal, 
the heparin infusion rate was reduced to 400 U/hour 
for a period of approximately 4 hours. The rate was 
then increased to the therapeutic rate 1 hour after 
sheath removal and the achievement of secure hemosta- 
sis. In patients in whom cardiopulmonary support was 
instituted, sufficient heparin was given to maintain the 
activated clotting time 2300 seconds for the duration 
of the procedure. After completion of the procedure, 
sheaths were removed either by elective vascular surgi- 
cal repair or by removal and prolonged compression af- 
ter the clotting parameters had returned to normal. 
Cons- Access site complications were de- 
fined as (1) local or retroperitoneal hemorrhage requir- 
ing the transfusion of 12 U of blood, (2) the need for 
surgical drainage or nonelective arterial repair of the 
access site, or (3) local or systemic infection requiring 
oral or intravenous antibiotic therapy. Patients under- 
going elective surgical removal of cardiopulmonary 
support device sheaths were not included. The cardiac 
catheterization procedures performed were classified 
as diagnostic procedures (including right-sided cardi- 
ac catheterization, selective coronary angiography, left 
ventriculography and aortography), conventional coro- 
nary balloon angioplasty (including the adjunctive use 
of intracoronary or systemic fibrinolytic therapy) or 
complex interventional procedures. The latter classifica- 
tion included aortic balloon valvuloplasty, and the use of 
new percutaneous coronary revascularization devices 
(directional coronary atherectomy, endovascular stents 
or laser ablation catheters), or circulatory support de- 
vices (intraaortic balloon counterpulsation or percutane 
ous cardiopulmonary bypass). Predictive risk factors for 
peripheral vascular complications were identified by 
comparing the prevalence of selected clinical variables 
(patient age, presence of 13 risk factors for coronary 
arterial disease, and the presence of peripheral vascular 
disease) and procedural variables (arterial sheath size, 
and use of intraprocedural heparin or periprocedural 
fibrinolytic therapy) in the group of patients with ac- 
cess site complications and in a group of 150 patients 
randomly selected from the computerized database of 
event-free cardiac catheterization procedures. 
Statistksr Differences in the incidence of complica- 
tions between groups were compared using chi-square 
analysis. Univariate chi-square analysis with a Bonfer- 
roni correction for multiple comparisons was performed 
to identify individual clinical and procedural factors 
predicting the likelihood of arterial complications. A 2- 
tailed probability value <0.05 was considered statisti- 
cally significant. 
RESULTS 
Acxeu site 0 During the study period, 
2,400 consecutive elective or emergency cardiac cathe- 
terization procedures were performed. These procedures 
included, 1,5 19 diagnostic procedures, 698 conventional 
coronary balloon angioplasties and 183 complex inter- 
ventional procedures. The complex procedures included 
69 coronary atherectomies, 25 coronary stent implanta- 
tions, 34 aortic valvuloplasties, and the use of an intra- 
aortic balloon pump in 45 patients and percutaneous 
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TABLE II Demographic Variables and Peripheral Vascular 
Complications 
Complication (%) No Complications (%) 
Variable (n = 39) (n = 150) 
Age 2 65 years 20 151) 39 (26) 
Men/women 21/18 (54/46) 105/45 (70/30) 
Systemic hypertension 22 (56) 56 (37) 
Diabetes mellitus 12 (31) 56 (15) 
Cigarette smoking 24 (62) 75 (50) 
Hypercholesterolemia 22 (56) 55 (34) 
Peripheral vascular dis- 11 (28) 15 (10) 
ease 
Obesity (body mass in- 8 (21) 65 (43) 
dex 228 kg/m*) 
cardiopulmonary bypass support in 10 patients. Access 
site complications were identified in 36 patients (21 
men, 15 women) after 39 procedures, each of which was 
performed using a percutaneous femoral arterial ap 
preach. The incidence of complications after diagnostic 
procedures was O-6%, after conventional balloon angio- 
plasty 2.6%, and after complex interventional proce 
dures 6.6% (p <O.OOOl) (Figure 1). Complications oc- 
curred in 4% of patients requiring intraaortic balloon 
counterpulsation, in 6% of patients undergoing atherec 
tomy, 6% after aortic valvuloplasty, 8% after coronary 
stent implantation, and 20% after use of percutaneous 
cardiopulmonary support. 
The complications encountered were predominantly 
associated with femoral arterial injury that occurred af- 
ter 21 procedures (Table I). The most frequent injury 
was a femoral arterial pseudoaneurysm, which was 
identified by color flow Doppler imaging or at the time 
of surgery. Five of the 8 pseudoaneurysms were surgi- 
cally repaired and 3 were treated conservatively. Each 
of the other vascular complications, including a femoral 
arterial laceration in 6 patients, arterial occlusion or 
thromboembolism in 3 patients, and femoral arteriove 
nous ffitulas in 3 patients, required surgical treatment. 
Overall, surgical repair was required after 0.3% of diag- 
nostic procedures, 0.7% of conventional angioplasty pro- 
cedures and 3.8% of complex interventions (p <O.OOOl) 
(Figure 1). Blood transfusion of L2 U of blood was re- 
quired after 28 procedures (72%); 14 of these transfu- 
sions were administered to patients requiring vascular 
surgical repair of the access site and the remainder were 
TABLE Ill Univariate Analysis of Risk Factors 
Univariate Corrected Odds 
Variable Chr-Square p Value Ratio 95% Cl 
Arterial sheath size z8Fr 23.3 < 0.001 5.0 2.3-10.6 
Thrombolytic therapy 29.0 <O.OOl 4.9 3.2-7.4 
Periprocedural heparin 20.8 <O.OOl 4.2 2.1-8.6 
Age 2 65 years 9.8 0.01 2.4 1.4-4.1 
Peripheral vascular dis- 8.2 0.03 2.4 1.4-4.3 
ease 
2 3 coronary risk factors 2.3 0.06 2.3 1.3-4.0 
Cl = confidence interval. 
administered to patients with local hemorrhage who 
were treated nonsurgically. Antibiotic therapy was ad- 
ministered to 7 patients (Table I), each of whom had 
infection limited to the local access site with no evidence 
of systemic infection by multiple blood cultures. One 
patient died from multisystem organ failure after diag- 
nostic cardiac catheterization, and 1 patient died 24 
hours after coronary balloon angioplasty from abrupt 
closure of the dilated right coronary artery. In this se- 
ries, there were no postprocedural deaths after complex 
interventional procedures. 
Demographk tisk faetors for vasadar complka- 
tions: When compared with the 150 randomly selected 
patients without complications, patients with access site 
complications tended to be older, had a greater preva- 
lence of individual risk factors for atherosclerotic dis- 
ease and a higher incidence of peripheral vascular dis- 
ease, but had a lower incidence of obesity (defined as a 
body mass index 228 kg/m2, where body mass index = 
weight/height2) (Table II). By univariate analysis after 
correction for multiple comparisons, patient age 165 
years and the presence of peripheral vascular disease 
remained statistically significant risk factors (p = 0.01 
and p = 0.03, respectively) (Table III). 
Procehral risk factors for vasahr complkaths: 
The strongest procedural predictors of the likelihood of 
peripheral vascular complications were the use of large 
caliber introducing sheaths and the use of periproce- 
dural anticoagulant and librinolytic therapy (Tables III 
I Surgical repair 6.6 
Diagnostic PTCA Complex 
Fl6uREl.ccnmdmlofBlslnddemwef accessdtecenQll- 
caBammdnaadform8wkdblteNdh hMBantsundwrco- 
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TABLE IV Procedural Variables and Vascular Complications 
Complication No Complications 
(%) (%) 
Variable (n = 39) tn = 150) 
Procedure performed 
Diagnostic cardiac catheterization 6 (24) 100 (67) 
Coronary angioplasty 18 (46) 38 (25) 
Atherectomy 4 (10) 2 (1.3) 
Stent 2 (5) 3 (2.0) 
Valvuloplasty 2 (5) 3 (2.0) 
lntraaortic balloon pump 2 (51 2 (1.3) 
Cardiopulmonary support device 2 (5) 1 (0.7) 
Adjunctive therapy 
Preprocedural aspirin 36 (92) 110 (73) 
lntraprocedural heparin therapy 32 (83) 53 (35) 
lntraprocedural lytic therapy 11 (29) 2 (1.3) 
Procedural details 
Arterial sheath size 2 8Fr 32 (82) 56 (37) 
Procedure duration > 2 hours 17 (43) 5 (3) 
Sheaths in situ > 24 hours 5 (14) - 
and IV). Arterial sheaths with a caliber >-8Fr were 
used in 82% of patients who developed complications 
compared with 37% of those without complications (p 
<O.OOl); arterial sheath sizes Z9Fr were used in 29% 
of patients with arterial complications. Intraprocedural 
heparin was administered to 83% of patients with com- 
plications compared with 35% of event-free patients 
(p <O.OOl), and tibrinolytic therapy was used in 29 
and 1.4% of patients, respectively (p <O.OOl). The pre 
procedural use of aspirin was also somewhat higher in 
the complicated group (92 vs 73%). In the group with 
arterial complications, 43% underwent cardiac catheter- 
ization lasting >2 hours, and in 14% the arterial sheaths 
remained in situ for >24 hours because of the peripro- 
cedural administration of fibrinolytic therapy or the 
need for uninterrupted postprocedural anticoagulant 
therapy* 
DISCUSSION 
The principal fmdings of this study are that the inci- 
dence of peripheral arterial complications after complex 
interventional procedures is signitlcantly higher than af- 
ter conventional diagnostic and therapeutic procedures. 
The incidence of complications was most closely associ- 
ated with the use of large caliber introducing sheaths 
and the use of periprocedural anticoagulant or fibrin+ 
lytic therapy. 
vasalbtxmphem~~urdkc 
B Several large, multicenter regis- 
t.rie~rJ+**~ and single center studiesloJ1 have documented 
the frequency of vascular complications after diagnostic 
cardiac catheterization. In studies that have excluded 
patients aged <l year, the incidence of arterial compli- 
cations has ranged from 0.2 to 1.9%, depending on the 
access site. In general, thrombotic ischemic arterial 
complications have been somewhat higher after proce- 
dures performed from the bra&al approach than from 
the femoral route, but the latter approach has been as- 
sociated with a higher incidence of hemorrhagic compli- 
cations.1*2~8-11 The overall incidence of 0.6% and the 
need for surgical repair in 0.3% in thii study is compa- 
rable to that noted for femoral vascular access in the 
larger series. 
-w--e 
neoustra- eomuty dmg@Myz The overall 
incidence of vascular complications after conventional 
FICA in this study (2.6%), and the need for operative 
arterial repair (0.7%), also compare favorably with the 
frequencies quoted in previous reports. Two single cen- 
ter studies have compared the incidence of local vascu- 
lar access site complications after diagnostic cardiac 
catheterization and conventional FTCA.12J3 In these 
studies, coronary angioplasty was not associated with an 
increased incidence of complications but, in both stud- 
ies, the frequency of vascular complications after diag- 
nostic procedures was relatively high. In the study of 
Wyman et a1,12 surgical repair of the femoral artery 
was required after 1.6% of diagnostic procedures com- 
pared with 1.5% after coronary angioplasty, and Kauf- 
man et all3 noted an incidence of vascular complications 
of O.% after coronary angioplasty compared with 1.2% 
after diagnostic procedures. Three other studies have re- 
ported the incidence of peripheral vascular complica- 
tions after FTCA.3J4J5 In the 1977 to 1981 National 
Heart, Lung, and Blood Institute’s FTCA registry of 
1,500 patients,3 local vascular complications occurred 
after 1.5% of the procedures, and in 2 large studies from 
Emory University, vascular complications occurred af- 
ter 0.6% of 3,500 coronary angioplasties performed be 
tween 1980 and 1984,14 and 1% of 4,988 PTCA proce- 
dures performed between 1985 and 1988.15 In the lat- 
ter study, peripheral vascular complications correlated 
strongly with patient age and the postprocedural use of 
heparin. 
Compkx earamy htemnWd pmadmsi Over 
the past 10 years, an increasing number of percutaneous 
coronary interventions have been performed in patients 
with unstable coronary syndromes, severe multivessel 
coronary artery disease, complex coronary lesion mor- 
phology, previous coronary artery bypass graft surgery 
and severely impaired left ventricular function.4 In an 
effort to improve the safety of these high-risk proce 
dures, a variety of new devices have been developed to 
reduce the likelihood of arterial dissection and abrupt 
closure, or to provide circulatory support in the event of 
profound myocardial ischemia and dysfunction. The use 
of these devices has necessitated the placement of large 
caliber catheters in peripheral arteries and veins, often 
in association with intensive anticoagulation or the ad- 
ministration of fibrinolytic therapy. Although previous 
reports have described the frequency of access site com- 
plications occmring after the use of some of these de 
vice~,~J~ no study has previously compared the vascular 
morbidity of these new procedures with that of conven- 
tional coronary interventions. 
One of the earliest devices used to increase the safe- 
ty of conventional FICA was the intraaortic balloon 
pump. Several studies have reported an increased inci- 
dence of vascular complications and sepsis after the use 
of these devices.19-22 In these studies, the need for vas- 
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cular surgical repair ranged from 10.7 to 37% and cor- 
related with a history of diabetes mellitus,i9~21 the pres- 
ence of peripheral vascular disease,19 and with pro- 
longed circulatory support (>20 days).20 In the current 
study, the use of intraaortic balloon pumping for high- 
risk coronary interventions was associated with an inci- 
dence of access site complications of only 4.4%. The fre 
quency of complications reported after the use of percu- 
taneous cardiopulmonary support devices has also been 
high.23*24 In 1 single center experience, vascular repair 
was required after ~O??J of procedures in which cardio 
pulmonary support was used, and 30% of the patients 
required blood transfusion.23 Vascular morbidity was 
also high in a report from a multicenter cardiopulmo- 
nary support registry24; blood transfusion was required 
in 43% of 105 patients and significant arterial injury 
occurred in 26% of the study group. In the current 
study, 2 of 10 patients treated with percutaneous car- 
diopulmonary support required both nonelective vascu- 
lar surgical repair and blood transfusion. 
Relatively little has been published on the frequency 
of arterial complications after coronary atherectomy or 
stent implantation. In 1 study, vascular surgical repair 
was required in 2% of 67 patients after coronary ather- 
ectomy.5 After Pahnaz-Schatz stent implantation, 10 of 
174 patients (5.7%) treated with the current intensive 
anticoagulant regimen required blood transfusion or 
vascular surgical repair. I8 In our own experience, al- 
though the incidence of access site complications was 
8% in this study, the need for blood transfusion has been 
as high as 15% after elective stent implantation.25*26 
This high incidence of bleeding was attributed to exces- 
sive anticoagulation with heparin and has fallen consid- 
erably since the introduction of more vigorous monitor- 
ing of the patients’ coagulation status. Aortic balloon 
valvuloplasty, another procedure requiring the use of 
large caliber introducing sheaths and balloon catheters, 
has been associated with major vascular complication 
rates ranging from 7 to 1oo/012*27 and in 1 series2* was 
associated with the need for leg amputation in 3 of 492 
(0.6%) patients. A similar incidence of complications 
was noted in this study. 
CO&al knpliccltiom: In the current study, the stron- 
gest predictors of the need for vascular surgical repair, 
blood transfusion or systemic antibiotic therapy after 
percutaneous cardiovascular interventional procedures 
were the size of the arterial catheters, and the use of 
anticoagulant or librinolytic therapy. Patient age and 
the presence of peripheral vascular disease were also im- 
portant variables, but patient gender, individual risk 
factors for coronary artery disease, obesity and the ex- 
tent of coronary disease did not appear to be important 
factors. These findings suggest that the incidence of vas- 
cular complications might be reduced by further techni- 
cal refinements such as a reduction in device caliber. In 
recent years, the caliber of directional coronary atherec- 
tomy catheters, intraaortic balloon pumps and the arte- 
rial and venous catheters of the percutaneous cardiopul- 
monary support device have all been effectively re 
duced. Furthermore, a reduction in the profile of both 
fmed-wire and over-thewire balloon angioplasty sys- 
tems has permitted an increasing number of coronary 
angioplasties to be performed through 6 and 7Fr guid- 
ing catheters.29 Efforts to reduce the thrombogenicity of 
metallic stents are also clearly warranted so that the 
need for intensive antiplatelet and antithrombotic thera- 
py may be reduced. Finally, although less predictive of 
the likelihood of complications, patient selection re- 
mains an important consideration, particularly in the 
choice of 2 procedures of apparently equivalent efficacy 
in elderly patients or those with overt peripheral vascu- 
lar disease. 
Study limitationsr The relatively small number of 
access site complications in this study limits the number 
of clinical and procedural variables that can be legiti- 
mately evaluated as predictive factors. Similarly, the 
low event rate does not permit any direct comparison of 
the likelihood of complications after the respective coro- 
nary interventional procedures. Finally, multivariable 
regression analysis was not performed, the variables 
identified by univariate analysis may thus be interre- 
lated. 
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